Immunogenetic and Cytokine Profile Alterations in Autism Spectrum Disorder: A Clinical Study

Autism Spectrum Disorder (ASD) is a multifactorial neurodevelopmental disorder with complex interactions between genetic susceptibility, immune dysfunction, and environmental influences. Accumulating evidence suggests that immune system abnormalities, particularly cytokine dysregulation, may interact with genetic vulnerability factors to influence neurodevelopmental trajectories. The broad phenotypic variability observed in ASD raises the possibility that distinct immunogenetic mechanisms underlie different clinical presentations. This study was designed to investigate immunogenetic and cytokine profile alterations in children diagnosed with Autism Spectrum Disorder, with particular emphasis on inflammatory mediators and their potential relationship to immune-related pathogenic mechanisms. A clinical case–control framework was employed to assess circulating cytokines, including IL-6, IL-27, IL-37, IL-29, TNF-α, and IFN-γ, alongside immunoglobulin levels (IgG and IgM). Quantitative immunological assays were utilized to determine serum concentrations. The study further explored the theoretical framework of immunogenetic interaction by analyzing cytokine alterations in the context of potential genetic susceptibility and immune pathway activation. Statistical evaluation was conducted to identify significant immunological differences and possible mechanistic associations. Children with ASD exhibited significant cytokine profile alterations, characterized by enhanced pro-inflammatory responses and modified regulatory cytokine activity. Elevated IL-6, TNF-α, and IFN-γ levels suggest persistent immune activation and possible neuroinflammatory signaling. Variations in IL-27 and IL-37 indicate disruption in immune regulatory balance. These findings support the concept that ASD may involve immune-mediated mechanisms influenced by genetic predisposition affecting cytokine signaling pathways. The integration of cytokine data with immunogenetic perspectives highlights a potential mechanistic link between systemic immune alterations and altered neurodevelopment. The present clinical study provides evidence supporting an immunogenetic framework for Autism Spectrum Disorder, wherein cytokine dysregulation may represent both a biological marker and a mechanistic contributor to disease development. Understanding the interplay between immune signaling molecules and genetic vulnerability may facilitate the identification of biologically defined ASD subtypes and open avenues for targeted immunomodulatory interventions

• Publication year

  2026

• Venue

  International Journal of Natural and Health Sciences

• Publication date

  2026-02-26

• Fields of study

  Not labeled

• Identifiers
  DOI 10.59890/ijnhs.v4i1.174
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral Health Status in Autism Patients Children in Iraq

  2021cited by this paper
• Cytokine expression profiles in Autism spectrum disorder: A multi-center study from Turkey.

  2020cited by this paper
• Biomarkers in Autism Spectrum Disorders: Current Progress.

  2019cited by this paper
• Cytokine Profile in Autism Spectrum Disorders in Children

  2016cited by this paper
• Decreased Numbers of CD57+CD3- Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder.

  2016cited by this paper
• Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children

  2014cited by this paper
• Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.

  2013cited by this paper
• Hypothesis: The Role of Sterols in Autism Spectrum Disorder

  2011cited by this paper
• Pathogen Recognition by the Innate Immune System

  2011cited by this paper
• Cytokines and CNS development.

  2009cited by this paper
• Innate and adaptive immune responses of the central nervous system.

  2006cited by this paper
• Immunoglobulin

  2006cited by this paper
• Elevated cytokine levels in children with autism spectrum disorder.

  2006cited by this paper
• CNS immune privilege: hiding in plain sight

  2006cited by this paper
• The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms.

  2005cited by this paper
• Multi-site Study of the Childhood Autism Rating Scale (CARS) in Five Clinical Groups of Young Children

  2005cited by this paper
• [Autism and pervasive developmental disorders].

  2004cited by this paper
• Pervasive developmental disorders in preschool children.

  2001cited by this paper

• No citing papers are available for this paper.